EmulsiFlex-C3 Homogenizer

Summary (Newest Update)

Background The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Avestin Inc. as Avestin Inc. is the only known responsible source capable of providing the required products and services that meet NIH's standards. The contract is specifically for the National Institute of Diabetes and Digestive and Kidney Diseases, which requires an EmulsiFlex homogenizer for their Laboratory of Molecular Biology. This equipment is crucial for high-pressure cell disruption, supporting protein extraction and purification from biological samples, which is essential for studying biological processes and disease mechanisms. Work Details The contract involves the procurement of an EmulsiFlex-C3 Homogenizer equipped with a heat exchanger and heat exchange coil. The system is necessary for high-pressure cell disruption to facilitate protein extraction and purification from biological samples. Key points include: - Requirement: EmulsiFlex homogenizer with heat exchanger and heat exchange coil - Purpose: High-pressure cell disruption for protein extraction and purification - Importance: Reliable protein purification is critical for research on biological processes and disease mechanisms; without this system, sample preparation will be delayed, negatively impacting research productivity and experimental timelines. Place of Performance The product will be delivered to the National Institute of Diabetes and Digestive and Kidney Diseases.